Publicaciones en colaboración con investigadores/as de Hospital Universitario Puerta de Hierro (19)

2023

  1. Real-world safety and effectiveness of maintenance niraparib for platinum-sensitive recurrent ovarian cancer: A GEICO retrospective observational study within the Spanish expanded-access programme

    European Journal of Cancer, Vol. 182, pp. 3-14

  2. SARS-CoV-2 infection in patients with melanoma: results of the Spanish Melanoma Group registry

    Clinical and Translational Oncology, Vol. 25, Núm. 3, pp. 768-775

2020

  1. Final Overall Survival Analysis of the SOGUG Phase 2 MAJA Study: Maintenance Vinflunine Versus Best Supportive Care After First-Line Chemotherapy in Advanced Urothelial Carcinoma

    Clinical Genitourinary Cancer, Vol. 18, Núm. 6, pp. 452-460

  2. The PALBONET Trial: A Phase II Study of Palbociclib in Metastatic Grade 1 and 2 Pancreatic Neuroendocrine Tumors (GETNE-1407)

    Oncologist, Vol. 25, Núm. 9, pp. 745-e1265

2017

  1. Axitinib treatment in advanced RAI-resistant differentiated thyroid cancer (DTC) and refractory medullary thyroid cancer (MTC)

    European Journal of Endocrinology, Vol. 177, Núm. 4, pp. 309-317

  2. Capecitabine and temozolomide in grade 1/2 neuroendocrine tumors: A Spanish multicenter experience

    Future Oncology, Vol. 13, Núm. 7, pp. 615-624

2014

  1. Cost analysis of skeletal-related events in Spanish patients with bone metastases from solid tumours

    Clinical and Translational Oncology, Vol. 16, Núm. 3, pp. 322-329

2013

  1. Prevalence and management of anaemia in patients with non-myeloid cancer undergoing systemic therapy: A Spanish survey

    Clinical and Translational Oncology, Vol. 15, Núm. 6, pp. 477-483

2012

  1. Erlotinib and chemoradiation in patients with surgically resected locally advanced squamous cell carcinoma of the head and neck: A GICOR phase I trial

    Annals of Oncology, Vol. 23, Núm. 4, pp. 1005-1009

2010

  1. Treatment of cancer with oral drugs: A position statement by the Spanish Society of Medical Oncology (SEOM)

    Annals of Oncology

2009

  1. Management of platinum-resistant ovarian cancer with the combination of pemetrexed and gemcitabine

    Clinical and Translational Oncology, Vol. 11, Núm. 1, pp. 35-40

2008

  1. A prospective observational study of the effectiveness, safety, and effect on fatigue of darbepoetin alfa for the treatment of chemotherapy-induced anaemia

    Current Medical Research and Opinion, Vol. 24, Núm. 10, pp. 2931-2942

  2. Randomised study of single dose (8 Gy vs. 6 Gy) of analgesic radiotherapy plus zoledronic acid in patients with bone metastases

    Clinical and Translational Oncology, Vol. 10, Núm. 5, pp. 281-287

2005

  1. Erythropoietin in cancer treatment: Considerations about Henke's article

    Clinical and Translational Oncology

2004

  1. Radioterapia y anemia: Nuevas bases

    Oncologia

1983

  1. ENFERMEDAD DE HODGKIN, ESTADIO II FACTORES PRONOSTICO EN 96 ENFERMOS TRATADOS CON RADIOTERAPIA EXCLUSIVA O RADIOTERAPIA Y QUIMIOTERAPIA

    Oncologia 80, Vol. 8, Núm. 1, pp. 17-22

  2. Intracranial tumors with risk of dissemination in neuroaxis

    International Journal of Radiation Oncology, Biology, Physics, Vol. 9, Núm. 9, pp. 1297-1301

  3. Radiation therapy in craniopharyngiomas

    International Journal of Radiation Oncology, Biology, Physics, Vol. 9, Núm. 4, pp. 493-496

1982

  1. PERFIL CLINICO Y RADIOTERAPIA RADICAL EN EL CARCINOMA DE ENDOMETRIO

    Radiologia, Vol. 24, Núm. 5, pp. 375-378